Injective Protocol's INJ token traded at $7.34 on October 7, 2026, declining 5.14% over the prior 24 hours. The move extended a modest weekly pullback, with the asset also down 4.25% over the past seven days.
Despite the short-term softness, the token's 30-day performance tells a different story. INJ has gained 29.55% over the past month, suggesting the recent dip follows a period of considerable appreciation.
The asset's market capitalization stood at $0.75 billion at the time of reporting. Trading in broader crypto markets has shown mixed signals, and INJ's daily decline places it among underperformers on the session.
The contrast between the token's 30-day strength and its near-term weakness reflects the volatility common to mid-cap digital assets. No single catalyst was identified in the available data to explain Tuesday's move.
